Bone Biologics

Bone Biologics

A publicly-held Biotechnology Company.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
EBITDA(<1m)(1.1m)(4.4m)(9.9m)---
Profit(1.8m)(1.6m)(1.5m)(8.9m)(8.3m)(4.4m)(4.6m)
EV / EBITDA-278.9x-33.1x-0.7x-0.2x---
R&D budget<1m<1m1.6m6.9m---
  • Edit
DateInvestorsAmountRound

$2.0m

Seed
N/A

$5.8m

Post IPO Equity
N/A

N/A

IPO

$1.4m

Post IPO Equity

$500k

Post IPO Equity
N/A

$2.0m

Post IPO Debt
*
N/A

$5.1m

Post IPO Equity
*
N/A

$5.0m

Post IPO Equity
*
N/A

$729k

Private Placement VC
*
N/A

$2.1m

Post IPO Equity
Total Funding$2.7m

Recent News about Bone Biologics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.